For instance, glioma cells with mutant EGFR express IL‐6 and/or LIF cytokines, which can activate amplified wild‐type EGFR in neighboring cells, resulting in enhanced proliferation (Inda et al., 2010). This evidence concerns the gene EGFR and central nervous system cancer.